|Outsourcing Outlook Eric Langer Another In-House Operation Gets Outsourced|
|Regulatory Watch Jill Wechsler Quality Systems Key to Lifecycle Drug Management|
|European Regulatory Watch Sean Milmo EU's New Post-Authorization Variations Framework Comes Under Scrutiny|
Keith Moore will support Metrics Contract Services as vice president of analytical services.
Catalent’s licensing of Excelimmune’s antibody combination therapy platform can enable the manufacture of multiple recombinant antibodies in a single batch culture.
The 12th Annual Report and Survey of Biomanufacturing is now available.